“Atorvastatin Administration’s Effect on FVII and FXI Activity and Fibrin Clot Properties in VTE Patients and Healthy Subjects”

https://pubmed.ncbi.nlm.nih.gov/38117119

Three days of atorvastatin administration reduced FVII and FXI activity, which was associated with favorable changes in fibrin clot properties in both VTE patients and healthy subjects.